版本:
中国

BRIEF-Orexigen Therapeutics reports Q1 loss per share $4.67

May 9 Orexigen Therapeutics Inc

* Orexigen Therapeutics reports financial results for the first quarter ended March 31, 2017

* Q1 loss per share $4.67

* Q1 revenue $19.1 million

* Orexigen Therapeutics Inc - As of March 31, 2017, Orexigen had $126.6 million in cash, restricted cash and cash equivalents and marketable securities Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐